IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test Profile

IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test Profile Abdul Rahman Wed, May 27, 2026 at 11:56 PM GMT+2 2 min read IDXX IDEXX Laboratories, Inc. (NASDAQ: IDXX ) is one of the best medical technology stocks to buy right now . On May 19, IDEXX Laboratories, Inc.

(NASDAQ:IDXX) announced that its SDMA kidney biomarker will be built directly into Catalyst CLIPs. Catalyst CLIPs is the most widely used point-of-care chemistry profiles on the company’s Catalyst platform. IDEXX said this integration will roll out to customers in the United States and Canada starting next month.

IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test Profile SDMA, short for symmetric dimethylarginine, measures how efficiently the kidneys filter waste from the blood. Its key advantage over the traditional marker creatinine is that it can flag a kidney function decline as early as 25-40% loss. Contrarily, creatinine often doesn’t register a problem until up to 75% of kidney function is already gone, as per IDEXX.

The company added that previously, veterinarians who wanted SDMA data had to order it as a separate test. Now, the data will be embedded within the Chem 11, Chem 16, and Chem 18 Catalyst CLIPs profiles at no additional cost. The results will flow automatically into IDEXX’s VetConnect PLUS diagnostic data platform.

IDEXX’s CEO Mike Erickson spoke of the move as a scaling strategy, noting that “SDMA is a clear example of how IDEXX innovates by developing clinically relevant diagnostics and then scaling their impact through platforms veterinarians already use every day. ” IDEXX Laboratories, Inc. (NASDAQ:IDXX) is a medical technology company focused on diagnostic and information technology solutions for animal health.

The company develops and sells veterinary diagnostic instruments, laboratory services, rapid test kits, and software platforms used by veterinary clinics and hospitals worldwide. While we acknowledge the potential of IDXX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the   best short-term AI stock .

READ NEXT:  7 Best Augmented Reality Penny Stocks to Buy and 10 Best Gene Therapy Stocks to Buy in 2026 . Disclosure: None. Follow Insider Monkey on Google News .